Genetic Analysis AS: New Infant Gut Microbiota Screening Test Provides Key Tool for Disease Development Investigation
OSLO--(BUSINESS WIRE)--Genetic Analysis AS, the molecular diagnostics company, has launched its GA-map™ microarray test for high throughput screening of infant gut microbiota. At the recent Sackler Colloquium on Microbes and Health in the US, the company presented data from evaluation screens that show its potential as a tool for probing the mechanisms of disease in conditions associated with the gut flora.